[go: up one dir, main page]

AR081661A1 - Composiciones vacunales a base de sticholisina encapsulada en liposomas - Google Patents

Composiciones vacunales a base de sticholisina encapsulada en liposomas

Info

Publication number
AR081661A1
AR081661A1 ARP110102211A ARP110102211A AR081661A1 AR 081661 A1 AR081661 A1 AR 081661A1 AR P110102211 A ARP110102211 A AR P110102211A AR P110102211 A ARP110102211 A AR P110102211A AR 081661 A1 AR081661 A1 AR 081661A1
Authority
AR
Argentina
Prior art keywords
sticholisine
liposomes
encapsulated
compositions based
vaccinal compositions
Prior art date
Application number
ARP110102211A
Other languages
English (en)
Inventor
Valcarcel Carlos Manuel Alvarez
Ruiz Maria Eliana Lanio
Molina Luis Enrique Fernandez
Santos Isabel Fabiola Pazos
Santos Liem Canet
Quintana Rady Judith Laborde
Lorenzo Maria Del Carmen Luzardo
Pardillo Circe Mesa
Garay Aisel Valle
Martinez Mayra Tejuca
Biosca Maria Eugenia Alonso
Leal Yoelys Cruz
Original Assignee
Centro Inmunologia Molecular
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44533576&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR081661(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Centro Inmunologia Molecular filed Critical Centro Inmunologia Molecular
Publication of AR081661A1 publication Critical patent/AR081661A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Reivindicación 1: Un vehículo vacunal para inducir respuesta inmune celular caracterizado porque comprende la encapsulación en vesículas lipídicas de proteínas obtenidas de la anémona Stichodactyla helianthus junto con un antígeno.Reivindicación 2: El vehículo vacunal de la reivindicación 1 caracterizado porque la vesícula lipídica contiene DPPC y Cho en una relación equimolar.
ARP110102211A 2010-07-06 2011-06-24 Composiciones vacunales a base de sticholisina encapsulada en liposomas AR081661A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20100144A CU20100144A7 (es) 2010-07-06 2010-07-06 Composiciones vacunales a base de sticholisina encapsulada en liposomas

Publications (1)

Publication Number Publication Date
AR081661A1 true AR081661A1 (es) 2012-10-10

Family

ID=44533576

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP110102211A AR081661A1 (es) 2010-07-06 2011-06-24 Composiciones vacunales a base de sticholisina encapsulada en liposomas

Country Status (24)

Country Link
US (1) US8697093B2 (es)
EP (1) EP2591802B1 (es)
JP (1) JP5685646B2 (es)
KR (1) KR101455055B1 (es)
CN (1) CN102971011B (es)
AR (1) AR081661A1 (es)
AU (1) AU2011276812B2 (es)
BR (1) BR112012033284B1 (es)
CA (1) CA2802443C (es)
CL (1) CL2012003674A1 (es)
CO (1) CO6640312A2 (es)
CU (1) CU20100144A7 (es)
EA (1) EA025333B1 (es)
ES (1) ES2576851T3 (es)
MX (1) MX2012015173A (es)
MY (1) MY167896A (es)
PE (1) PE20130390A1 (es)
PH (1) PH12013500036A1 (es)
SG (1) SG186931A1 (es)
TN (1) TN2012000592A1 (es)
TW (1) TWI457145B (es)
UA (1) UA111944C2 (es)
WO (1) WO2012003814A1 (es)
ZA (1) ZA201300059B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2891495B1 (en) * 2012-08-28 2018-05-30 National University Corporation Hokkaido University Lipid membrane structure including bacterial cell component having dispersibility in non-polar solvent, and method for producing same
KR102069670B1 (ko) * 2017-03-02 2020-01-23 단디바이오사이언스 주식회사 면역활성물질을 포함하는 다중도메인캡슐, 이의 제조방법, 및 이를 포함하는 면역조절 조성물
CA3069019A1 (en) * 2017-07-10 2019-01-17 Immunovaccine Technologies Inc. Pharmaceutical compositions, methods for preparation using lipid vesicle particles of defined size, and uses thereof
CN113041346A (zh) * 2019-12-26 2021-06-29 复旦大学 一种细菌毒素疫苗及其在预防细菌感染中的用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU655823B2 (en) 1991-05-08 1995-01-12 Crucell Switzerland Ag Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof
EP1797895A1 (en) 2005-12-16 2007-06-20 Pevion Biotech Ltd. An adjuvant system comprising virosomes and liposomes
AU2006351536B2 (en) 2006-12-04 2011-11-24 National Agriculture And Food Research Organization Method for producing biomineral-containing substance and organic hydroponics method

Also Published As

Publication number Publication date
CN102971011A (zh) 2013-03-13
MX2012015173A (es) 2013-02-11
AU2011276812B2 (en) 2013-12-19
KR20130027547A (ko) 2013-03-15
CU20100144A7 (es) 2012-06-21
ZA201300059B (en) 2013-09-25
HK1177138A1 (en) 2013-08-16
SG186931A1 (en) 2013-02-28
ES2576851T3 (es) 2016-07-11
TWI457145B (zh) 2014-10-21
JP5685646B2 (ja) 2015-03-18
CA2802443A1 (en) 2012-01-12
EA025333B1 (ru) 2016-12-30
EA201291449A1 (ru) 2013-05-30
TN2012000592A1 (en) 2014-04-01
BR112012033284B1 (pt) 2021-05-18
CO6640312A2 (es) 2013-03-22
MY167896A (en) 2018-09-26
JP2013530190A (ja) 2013-07-25
CN102971011B (zh) 2014-12-03
US20130149376A1 (en) 2013-06-13
US8697093B2 (en) 2014-04-15
PE20130390A1 (es) 2013-04-11
CA2802443C (en) 2015-03-17
KR101455055B1 (ko) 2014-10-28
TW201217000A (en) 2012-05-01
AU2011276812A1 (en) 2013-01-10
EP2591802B1 (en) 2016-06-08
WO2012003814A1 (es) 2012-01-12
CL2012003674A1 (es) 2013-07-12
EP2591802A1 (en) 2013-05-15
PH12013500036A1 (en) 2013-02-18
UA111944C2 (uk) 2016-07-11
BR112012033284A2 (pt) 2017-05-02

Similar Documents

Publication Publication Date Title
MX2019014435A (es) Procedimientos para la fabricacion de un arn encapsulado en liposoma.
CY1122826T1 (el) Προ-συντηξης rsv f αντιγονα
ES2615214T3 (es) Soporte de sujetador en forma de X y sujetador que incorpora el mismo
CY1121232T1 (el) Τριαλκυλο κατιονικα λιπιδια και μεθοδοι χρησης αυτων
TR201908635T4 (tr) Protein kodlayıcı rna?nın lipozomal verilmesine uygun lipitler.
EP2392067A4 (en) PERMANENT ELECTRIC MOTORS ON MAGNET BASE
CY1120319T1 (el) Πρωτεϊνες συντηξης και εμβολια συνδυασμου που περιλαμβανουν haemophilus influenzae πρωτεϊνη ε και πιλινη α
AR081661A1 (es) Composiciones vacunales a base de sticholisina encapsulada en liposomas
MX377244B (es) Formulacion arn para inmunoterapia.
AR070679A1 (es) Polvo nutricional estable
CO6491045A2 (es) Composiciones de proteina f de virus sincitial respiratorio (rsv) y metodos para producir las mismas
EP3491126A4 (en) INTERNAL FIXED LIPID VESICLE
WO2013151706A3 (en) Subunit vaccine delivery platform for robust humoral and cellular immune responses
EP2858214A4 (en) IPM MOTOR FOR VACUUM PUMP
MX2015013832A (es) Composicion de vacuna y metodo de uso.
CY1123453T1 (el) Σκευασμα rna για ανοσοθεραπεια
WO2014179184A8 (en) Compositions for inducing immune tolerance to coagulation factor proteins
WO2014197991A8 (en) Compounds for promoting liposomal and cellular adhesion and compositions and methods of use thereof
EP2759760A4 (en) LED LAMP IN LIGHT BULB
ITRM20040066A1 (it) Metodo di identificazione di peptidi antigenici e relativo uso per la preparazione di un vaccino anti hiv-1.
EP2862873A4 (en) IGE PEPTIDE VACCINE
DE602006010061D1 (de) Malariaimpfstoffe
TH152506A (th) วิธีการเตรียมเมดีโทมิดีนด้วยคลอโรอะซีโตน
RU2010135365A (ru) Липкий провод
CY1117064T1 (el) Λιποσωματα με λιπιδια τα οποια εχουν μια πλεονεκτικη τιμη pka για χορηγηση dna

Legal Events

Date Code Title Description
FC Refusal